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Methods: We report the 20-year FU of 912 patients (pts) who had good
immediate results (IR) of PMC (valve area -1.5cm² with mitral regurgitation
-2/4). Mean age was 48±13 yrs, 251 pts (27%) had calcified valves.
Results: During a mean FU of 12 years, 351 pts (38%) required a repeat
intervention on the mitral valve. Surgery was performed in 266 pts (76%). A
repeat PMC could be performed in 85 pts (24%) a mean of 10±4 years after
the first PMC, with good IR in 80 pts (94%).
Survival without re-intervention was 38±2% at 20 years. When considering
surgery alone, the corresponding rate increased to 46±2% at 20 years. In the
504 pts aged <50 years at their first PMC, 20-year rates were 45±3% for sur-
vival without re-intervention and 57±3% for survival without surgery (Figure).
Conclusion: After successful PMC 1) Re-intervention is frequently needed
during long-term FU 2) Repeat PMC can be performed in one out of 4 pts
needing re-intervention. 3) Surgery can thus be further postponed in a substan-
tial number of patients. 4) The favourable impact of repeat PMC is particu-
larly marked in pts aged <50 years, enabling more than half of them to remain
free from surgery 20 years after initial PMC.
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Introduction: Early repolarization (ER) has been recently linked with
idiopathic ventricular fibrillation. In spite of a frequent familial past history of
SCD, ER identification in relatives is limited by variability of the ER over the
time and with the variation of autonomic tone and heart rate. The aim of the
study was to test the ability of valsalva maneuver (VM) to identify larges fam-
ilies affected by early repolarization syndrome (ERS).
Methods: We have screened relatives of 2 families in which SCD occurred
with ERS. Patients were considered to be affected in the presence of a positive
deflection on the S wave in two consecutive leads and at least a 1 mm ampli-
tude above baseline. A VM was performed in relatives to increase or reveal
ER. Comparison between heart rate and J wave amplitude before and after
VM was performed with a paired Student's t-test.
Results: VM was performed for 80 relatives. It increased ER amplitude in
17/20 (85%) affected patients and revealed ER in 17/60 (28%) patients unaf-
fected at rest. VM succeeded in unmasking pattern for 5/11 (45%) expected
carrier of ER previously considered as unaffected. Heart rate at rest was
75±13 bpm and decreased of 3,9±7,9 bpm (p<0,001) during the test without
any difference between groups.
In the first family, 4 SCD occured whose one with an ER pattern. We iden-
tified 25 other ER out of 82 available ECG (prevalence 34%).
In the second family, 4 SCD occurred whose one with an ER pattern. We
identified 17 other ER out of 29 available ECG (prevalence 58%).
In those families, ER is transmitted with an autosomal dominant trait
through respectively 5 and 4 generations.
Conclusion: Malignant forms of ER can be transmitted as an autosomal
dominant trait in large families. VM could be helpful to unmask ER for
familial screening of relatives. Further investigations are required to assess
prognosis of VM.
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Purpose: Recent trials have provided worrying safety data on certain oral
hypoglycemic drugs. The aim of this study was to assess 14-year risk of all-
cause mortality according to hypoglycemic drug exposure at baseline, in a
general population.
Methods: Our analysis was based on the Third French MONICA survey
(1995-1996). Participants aged 35-64 were randomly recruited from the gen-
eral population of three French areas. Vital status was obtained 14 years after
inclusion, and assessment of determinants of mortality was based on multi-
variable Cox modelling.
Results: There were 3403 participants and 272 deaths over the 14-year
period. At baseline, there were 3220 (95%) non-diabetic subjects, 48 (1%)
untreated diabetics and 135 (4%) diabetics with hypoglycemic drug treatment
(metformin alone (30%), sulfonylurea alone or in combination with other
hypoglycemic drugs except insulin (48%), insulin alone or in combination
with other hypoglycemic drugs except sulfonylurea (13%), other treatments
(9%)). Death rate was 7%, 23% and 21% in non-diabetic subjects, untreated
diabetics and diabetics with hypoglycemic drugs, respectively. A multivariate
analysis was performed with adjustment for duration of diabetes, history of
diabetes complications or severe chronic disease, and living area, age, gender,
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educational level, alcohol consumption, smoking, blood pressure, LDL- and
HDL-cholesterol. The adjusted Hazard Ratio for all-cause mortality was 2.77
[95% confidence interval: 0.70-10.88]
 
for untreated diabetics, 2.15 [0.91-5.08]
for diabetics with metformin alone, 1.53 [0.81-2.89]
 
for diabetics with sulfo-
nylurea (alone or in combination) and 5.03 [1.99-12.71]
 
for diabetics with
insulin (alone or in combination) versus non-diabetic subjects.
Conclusions: Diabetics treated with insulin at baseline were at increased
risk of all-cause mortality. We did not find any harmful signal regarding all-
cause mortality risk associated with the use of other hypoglycemic drugs. 
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In developed countries, cardiac valve diseases are one of the major
causes of mortality and morbidity. Aortic valve disease (AVD) including
aortic insufficiency or aortic stenosis, mainly develop as a consequence of
valvular degeneration. This defect was considered to be related to ageing
however it is now viewed as a multifactorial complex. Despite the impor-
tance of the AVD, its etiology is poorly understood. To assess this ques-
tion we’ve used mouse model. Thus, we have found that the transcription
factor Krox20 (also called Egr2) is expressed in the developing valves
during gestation and maintained after birth. Mice lacking Krox20 die at
birth due to respiratory defects. Hence, we have chosen to work with a
conditional allele of Krox20 (Krox20flox) allowing inactivation in endot-
helial-derived cells using the Tie2Cre transgenic mice. Cardiac function
analysis of Krox20 deficient mice was examined by magnetic resonance
imaging. This analysis reveals that Krox20 mutant mice develop an early
aortic insufficiency associated with a bicuspid aortic valve in 30%. Those
defects are usually associated with anomalies of the organization of the
extracellular matrix and abnormal proliferation during valve development.
Thus, Krox20 deficient embryos exhibit an increase of mesenchymal cell
proliferation and a reduction of the expression of some collagens including
type VI collagen. Moreover, the deficiency for Krox20 is associated with
the loss of the trilaminar organization of the adult valves. Our study
reveals an important role of Krox20 in heart valves development, remod-
elling and maturation.
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Long QT syndrome (LQTS) is a rare genetic cardiac disease, with clin-
ical variability, characterized by a prolongation of the QT interval on elec-
trocardiogram and risk of syncope and sudden death. Stratifying the risk
of cardiac events is important for the clinical management of the LQTS
patients. Thus, we investigated the role of genetic variants as modifiers of
cardiac event risk in LQTS patients carrying heterozygous KCNQ1 or
KCNH2 mutations.
We genotyped 25 candidate polymorphisms based on either their asso-
ciation with QTc (QT corrected for heart rate) duration in the general pop-
ulation, or their role in adrenergic response, in a matched case-control
study including 112 LQTS patient duos from France, Italy and Japan.
Duos were composed of two relatives harboring the same mutation; one of
whom experienced cardiac events whereas the other was asymptomatic and
untreated.
As expected, we observed that the presence of cardiac events was associ-
ated with longer QTc (490.7±49.1 ms in symptomatic vs. 462.2±39.8 ms in
asymptomatic patients, p=0.007). The NOS1AP rs12029454 A-allele showed
suggestive evidence of association with longer QTc (484.0±49.6 ms for car-
riers vs. 471.2±44.3 ms for non-carriers, p=0.006), and this effect was homo-
geneous in all ethnic groups. Carriers of the KCNQ1 rs2074238 T-allele
tended to have shorter QTc (464.1±34.9 ms for carriers vs. 479.1±44.0 ms for
non-carriers, p=0.04). This effect was restricted to the Caucasian population
because the SNP (Single Nucleotide Polymorphism) was not polymorphic in
our Japanese cohort. Interestingly, the rs2074238 T-allele was in addition sig-
nificantly associated with a decreased risk of cardiac events (OR=0.38 [0.27-
0.53], p=0.002).
Our results provide the first evidence that rs2074238 in KCNQ1 could be
a risk modifier for cardiac events in Caucasian LQTS patients. After confir-
mation in additional populations, this SNP may be clinically useful for risk
stratification in LQTS patients.
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Background: Oxidative stress and resulting inflammation may participate
in the pathophysiological mechanisms of aneurysm formation and ultimately
to aortic dissection. Aortic dissection more often occurs in the small curvature
(SC) of ascendant aortic aneurysms (AsAA), when compared to large curva-
ture (LC). We investigated the differential expression of oxidative stress and
inflammation in different parts of human aortic tissues, in particular in SC and
LC of patients with asymptomatic AsAA.
Methods: Aortic biopsies were obtained from 24 patients with asymptom-
atic AsAA undergoing elective open replacement, and each sample was
divided in four parts: SC, LC, anterior and posterior parts (A, P). Oxidative
stress was assessed by dihydroethidium (DHE) quantification and amount of
atherosclerosis plaque was determined by Oil Red O. NADPH oxidase subunit
expressions were assessed by PCR on NOX1, NOX2, NOX4 and NOX5.
Western blotting were performed to evaluate the expression of GP91phox,
p47phox, P-NF-B, and IL-1-.
Results: Oxidative stress, assessed by DHE, was around 20% higher in the
SC than other parts of the aortic wall (p<0.001), and lipid deposit was around
50% higher in the SC. A and P parts had the same pattern expression than LC.
NOX2 gene expression was also around 50% higher in SC than in LC whereas
NOX5 was around 20% lower (p<0.001). Expression of NOX1 was similar for
all the parts while NOX4 expression tended to be increased in SC. GP91phox,
p47phox, phosphorylated NF-B expression, and IL-1- expression were signif-
icantly higher in the SC than in the LC (p<0.001).
Conclusion: This study showed a regional heterogeneity of oxidative
stress in the aortic walls of patients withasymptomatic AsAA. Oxidative
stress was markedly higher in the SC than in the LC tissue, mainly linked
to increased NOX2 gene expression. These results further support the
